Literature DB >> 3298639

Vascularized bone transfer for limb salvage and reconstruction after resection of aggressive bone lesions.

R Gidumal, M B Wood, F H Sim, T C Shives.   

Abstract

At our institution from 1980 to 1985, 30 patients underwent resection of malignant or locally aggressive bone tumors, with limb salvage and reconstruction by free vascularized bone grafts. Of the 26 patients followed up for at least four months (average, 21 months), four had complications. In these four, there were three nonunions, two infections, and one stress fracture. The average duration of immobilization was 7.6 months in the lower extremity, five months in the pelvis, and 3.8 months in the upper extremity. The average time to union was 6.3 months in the lower extremity, five months in the pelvis, and five months in the upper extremity. Although the technique of oncologic reconstruction must be individualized, our experience indicates that vascularized bone grafts offer significant advantages over conventional methods in selected patients.

Entities:  

Mesh:

Year:  1987        PMID: 3298639     DOI: 10.1055/s-2007-1006983

Source DB:  PubMed          Journal:  J Reconstr Microsurg        ISSN: 0743-684X            Impact factor:   2.873


  4 in total

Review 1.  [Vascularized bone transfer].

Authors:  R Hierner; G Täger; D Nast-Kolb
Journal:  Unfallchirurg       Date:  2009-04       Impact factor: 1.000

2.  Endoprosthetic replacement of diaphyseal bone defects. Long-term results.

Authors:  E Aldlyami; A Abudu; R J Grimer; S R Carter; R M Tillman
Journal:  Int Orthop       Date:  2005-01-05       Impact factor: 3.075

3.  Immediate versus delayed free-tissue transfer salvage of the lower extremity in soft tissue sarcoma patients.

Authors:  G P Reece; M A Schusterman; R E Pollock; S S Kroll; M J Miller; B J Baldwin; M M Romsdahl; N A Janjan
Journal:  Ann Surg Oncol       Date:  1994-01       Impact factor: 5.344

4.  The versatility of the free osteocutaneous fibula flap in the reconstruction of extremities after sarcoma resection.

Authors:  Alexander D Bach; Jürgen Kopp; G Björn Stark; Raymund E Horch
Journal:  World J Surg Oncol       Date:  2004-07-01       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.